InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,995.54
(
0.38%
)
US TECH 100
20,562.00
(
0.10%
)
Dow Jones
43,988.99
(
0.59%
)
Brent Oil
73.89
(
0.00%
)
Bitcoin
76,614.61
(
0.06%
)
Post# of 2804248
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

whatisthecolorofmone

Send PM Follow Ignore
Followers 97
Posts 7001
Boards Moderated 0
Alias Born 09/16/2010

whatisthecolorofmone

Re: None

Wednesday, 04/22/2015 1:51:14 PM

Wednesday, April 22, 2015 1:51:14 PM

Post# of 2804248
$DVAX at 2015 ASCO Annual Meeting
May 31
Lymphoma and Plasma Cell Disorders
Session Type: Poster Session
Track(s): Lymphoma and Plasma Cell Disorders
Presentation(s):
Abstract #TPS8604
Phase I/II study of intratumoral injection of SD-101, an immunostimulatory CpG, and intratumoral injection of ipillumumab, an anti-CTLA-4 monoclonal antibody, in combination with local radiation in low-grade B-cell lymphomas.
Michael Siavash Khodadoust, MD, PhD
Stanford University

ASCO requires strict confidentiality regarding the content of posters and abstracts presented, until about 2 weeks before the meeting. After the end of that "quiet period," we may get a $DVAX press release regarding the ASCO poster presentation of interim results of this study.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up